TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    30.78
  • High
    32.32
  • Low
    30.59
  • Close
    31.48
  • Volume
    1,518,980

Financial ratios

Sep 30, 2024